OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 436 results

Filters: omadacycline

Omadacycline for the treatment of skin and soft tissue infections.
Antonio Vena, Nadia Castaldo, Daniele Roberto Giacobbe, Alberto Fantin, Matteo Bassetti
Curr Opin Infect Dis. Apr 01, 2025.38(2):122-127 Print-Electronic
Source:PubMed
PMID: 39786987 doi:10.1097/QCO.0000000000001089
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
S Ken Tanaka, Judith Steenbergen, Stephen Villano
Bioorg Med Chem. 12 15, 2016.24(24):6409-6419 Print-Electronic
Source:PubMed
PMID: 27469981 doi:10.1016/j.bmc.2016.07.029
Pathogens susceptible to tetracycline are also susceptible to omadacycline: tetracycline as a one-sided surrogate to predict omadacycline susceptible pathogens.
Alisa W Serio, Tiffany R Keepers, Kelly Wright, Diane Anastasiou
Diagn Microbiol Infect Dis. Nov, 2022.104(3):115785 Print-Electronic
Source:PubMed
PMID: 35988350 doi:10.1016/j.diagmicrobio.2022.115785
Omadacycline in treating community-based infections: a review and expert perspective.
George Sakoulas, Michael Nowak, Matthew Geriak
Expert Rev Anti Infect Ther. 03, 2023.21(3):255-265 Print-Electronic
Source:PubMed
PMID: 36718489 doi:10.1080/14787210.2023.2174100
Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics.
Keith A Rodvold, Rodrigo M Burgos, Xing Tan, Manjunath P Pai
Clin Pharmacokinet. 04, 2020.59(4):409-425 Print
Source:PubMed
PMID: 31773505 doi:10.1007/s40262-019-00843-4
Comparative activities of omadacycline, eravacycline and tigecycline against non-ESBL-producing, ESBL-producing and carbapenem-resistant isolates of .
Hasan Cenk Mirza, Aylin Üsküdar Güçlü, Gizem İnce Ceviz, Ahmet Başustaoğlu
J Med Microbiol. Oct, 2022.71(10): Print
Source:PubMed
PMID: 36301611 doi:10.1099/jmm.0.001592
Development of a UHPLC-MS/MS Method for the Determination of Omadacycline in Human Plasma.
Chuang Chen, Yao-Jie Chen, Jing Fu, Yu-Zhen Wang, Sun-Ting Qin, Meng-Yu Kong, Guan-Yang Lin, Xiu-Hua Zhang, Xu-Ben Yu
Ther Drug Monit. Feb 11, 2025.: Print-Electronic
Source:PubMed
PMID: 39937053 doi:10.1097/FTD.0000000000001308
Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial.
J C Cho, L M Childs-Kean, M T Zmarlicka, M P Crotty
Drugs Today (Barc). Mar, 2018.54(3):209-217 Print
Source:PubMed
PMID: 29771255 doi:10.1358/dot.2018.54.3.2800620
The pharmacokinetic evaluation of omadacycline (Oral Only Dosing Regimen) for the treatment of Community-Acquired Bacterial Pneumonia (CABP).
Catia Cilloniz, Antoni Torres
Expert Opin Drug Metab Toxicol. Sep, 2023.19(9):569-576 Print-Electronic
Source:PubMed
PMID: 37728376 doi:10.1080/17425255.2023.2261376
Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
Michael D Huband, Michael A Pfaller, Dee Shortridge, Robert K Flamm
J Glob Antimicrob Resist. 12, 2019.19:56-63 Print-Electronic
Source:PubMed
PMID: 30825698 doi:10.1016/j.jgar.2019.02.017
0